Sort   by:  
 Page size 
UnknownCD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy.
Not available
S-EPMC5713498 | biostudies-literature
UnknownPD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8<sup>+</sup> T-Cell-Driven Antitumor Immunity.
Not available
S-EPMC5959006 | biostudies-literature
UnknownAssociation of vision impairment and hearing impairment with encounters in the criminal justice system among children and young people: a systematic review and meta-analysis.
Not available
S-EPMC12593635 | biostudies-literature
UnknownDevelopment of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.
Not available
S-EPMC11028348 | biostudies-literature
UnknownDevelopment of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy.
Not available
S-EPMC7511290 | biostudies-literature
TranscriptomicsExposure of cystic fibrosis bronchial epithelial cells (CFBE 41 o-) to Pseudomonas aeruginosa (PA01) biofilms
In the clinical setting, mutations in the CFTR gene enhance the inflammatory response to P. aeruginosa (PA01) infection, but measurements of the inflammatory response to pathogen stimulation by isolated airway epithelia can yield variable results. In this series, we exposed CFBE41o- cells over-expre...
ORGANISM(S): Homo sapiens 
2011-07-31 | E-GEOD-30439 | biostudies-arrayexpress
ProteomicsSpatiotemporal proteomics of hormone treated mice (urine across time, prostate tissue)
Benign prostatic hyperplasia and related lower urinary tract symptoms remain common, costly, and impactful issues for aging males. Etiology and pathogenesis are multifactorial and include steroid hormone changes and inflammation. Noninvasive markers could one day inform personalized medicine, but in...
ORGANISM(S): Mus musculus (Mouse) 
2021-09-08 | PXD014416 | Pride
Mus musculus Urine Proteomics Hormone Prostate 
UnknownOn the Kinetics of Human Skin Mast Cell Depletion and Repopulation Following KIT Inhibition.
Not available
S-EPMC12862557 | biostudies-literature
UnknownPhase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.
Not available
S-EPMC4879709 | biostudies-literature
UnknownAnti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study.
Not available
S-EPMC9544977 | biostudies-literature
Sort   by:  
 Page size